186 related articles for article (PubMed ID: 9240877)
1. Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy.
Leger J; Ruiz JC; Guibourdenche J; Kindermans C; Garabedian M; Czernichow P
Acta Paediatr; 1997 Jul; 86(7):704-10. PubMed ID: 9240877
[TBL] [Abstract][Full Text] [Related]
2. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
[TBL] [Abstract][Full Text] [Related]
4. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial.
Meier C; Beat M; Guglielmetti M; Christ-Crain M; Staub JJ; Kraenzlin M
Osteoporos Int; 2004 Mar; 15(3):209-16. PubMed ID: 14727010
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
7. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
8. [The effects of levothyroxine replacement therapy on bone and mineral metabolism in patients with hypothyroidism].
Chai R; Ye Z; Zhan Z; Liu W; Yu M; Liu Y
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):18-21. PubMed ID: 11798620
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study.
Saggese G; Bertelloni S; Baroncelli GI; Costa S; Ceccarelli C
Eur J Pediatr; 1996 Jun; 155(6):452-7. PubMed ID: 8789760
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidism.
Salerno M; Lettiero T; Esposito-del Puente A; Esposito V; Capalbo D; Carpinelli A; Padula S; del Puente A
Eur J Endocrinol; 2004 Dec; 151(6):689-94. PubMed ID: 15588234
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.
Garton M; Reid I; Loveridge N; Robins S; Murchison L; Beckett G; Reid D
Clin Endocrinol (Oxf); 1994 Dec; 41(6):747-55. PubMed ID: 7889610
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.
Weber G; Mora S; Bellini A; Bosco M; Prinster C; Siragusa V; di Natale B; Chiumello G
J Endocrinol Invest; 1995 Apr; 18(4):277-82. PubMed ID: 7560809
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor genotype and bone mineral density in Caucasian children with congenital hypothyroidism.
Léger J; Tourrel C; Ruiz JC; Czernichow P; Garabedian M
J Pediatr Endocrinol Metab; 2000 Jun; 13(6):599-603. PubMed ID: 10905383
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.
Franklyn J; Betteridge J; Holder R; Daykin J; Lilley J; Sheppard M
Clin Endocrinol (Oxf); 1994 Oct; 41(4):425-32. PubMed ID: 7955453
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and metabolism in children treated with L-thyroxine.
Tümer L; Hasanoğlu A; Cinaz P; Bideci A
J Pediatr Endocrinol Metab; 1999; 12(4):519-23. PubMed ID: 10417967
[TBL] [Abstract][Full Text] [Related]
17. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
18. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
Lanes R; Gunczler P; Esaa S; Weisinger JR
Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
[TBL] [Abstract][Full Text] [Related]
19. Effect of replacement doses of thyroxine on bone mineral density.
Hanna FW; Pettit RJ; Ammari F; Evans WD; Sandeman D; Lazarus JH
Clin Endocrinol (Oxf); 1998 Feb; 48(2):229-34. PubMed ID: 9579237
[TBL] [Abstract][Full Text] [Related]
20. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
